SUBJECT
Title
Health technology assessment
Type of instruction
lecture
Level
master
Faculty
Part of degree program
Credits
4
Recommended in
Semester 2
Typically offered in
Spring semester
Course description
- Components of HTA
- Multicriteria decision analysis
- HTA implementation in high income countries
- Operation of HTA agencies; Joint HTA at European level
- HTA implementation in lower income countries
- Transferability of HTA
- Evidence synthesis / systematic literature review
- Collection of local data
- Critical appraisal of health technology assessment
- HTA of special technologies: medical devices and diagnostics
- HTA of technologies in rare diseases
- HTA of preventive medicine
Readings
- Drummond et al: Principles for the improved conduct of health technology assessment for resource allocation decisions, International Journal of Technology Assessment in Health Care, 24:3 (2008), 244–258.
- MCDA for Health Care Decision Making – An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
- Epstein D. The use of Comparative Effectiveness Research and Health Technology Assessment in European countries: current situation and prospects for the future http://www.ugr.es/~davidepstein/HTA%20in%20european%20countries.docx
- Kaló Z, Gheorghe A, Huic M, Csanádi M, Kristensen FB. HTA implementation roadmap in Central and Eastern European countries. Manuscript accepted for publication in Health Economics, 2015
- Drummond M, Augustovski F, Kaló Z, Yang BM, Pichon-Riviere A, Bae EZ, Kamal-Bhl S. Challenges faced in transferring economic evaluations to middle income countries. Int J Tech Assess HC, manuscript accepted for publication, 2016
- Inotai A, Pékli M, Jóna G, Nagy O, Remák E, Kaló Z. Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology. BMC Health Serv Res. 2012. 21. 12. 1. 332.
- Toumi M, Pashos CL, Korchagina D, Redekop K, Morel T, Blanchette C, Kaló Z, Simoens S, Gatermann R, Molsen E. Challenges in Assessing and Appraising Rare Disease Diagnostics & Treatments, ISPOR SIG Report 2015
- Inotai A, Pékli M, Jóna G, Nagy O, Remák E, Kaló Z. Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology. BMC Health Serv Res. 2012. 21. 12. 1. 332.